138 related articles for article (PubMed ID: 30257884)
21. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
22. The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus.
Kim CJ; Lee CG; Jung JY; Ghosh A; Hasan SN; Hwang SM; Kang H; Lee C; Kim GC; Rudra D; Suh CH; Im SH
Immunity; 2018 Dec; 49(6):1034-1048.e8. PubMed ID: 30566881
[TBL] [Abstract][Full Text] [Related]
23. A pathogenic role for ER stress-induced autophagy and ER chaperone GRP78/BiP in T lymphocyte systemic lupus erythematosus.
Lee WS; Sung MS; Lee EG; Yoo HG; Cheon YH; Chae HJ; Yoo WH
J Leukoc Biol; 2015 Feb; 97(2):425-33. PubMed ID: 25516752
[TBL] [Abstract][Full Text] [Related]
24. Update on the role of autophagy in systemic lupus erythematosus: A novel therapeutic target.
Pan Q; Gao C; Chen Y; Feng Y; Liu WJ; Liu HF
Biomed Pharmacother; 2015 Apr; 71():190-3. PubMed ID: 25960235
[TBL] [Abstract][Full Text] [Related]
25. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
Lettesjö H; Burd GP; Mageed RA
J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
[TBL] [Abstract][Full Text] [Related]
26. miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice.
Xin Q; Li J; Dang J; Bian X; Shan S; Yuan J; Qian Y; Liu Z; Liu G; Yuan Q; Liu N; Ma X; Gao F; Gong Y; Liu Q
J Immunol; 2015 Jun; 194(11):5437-45. PubMed ID: 25911753
[TBL] [Abstract][Full Text] [Related]
27. A switch from canonical to noncanonical autophagy shapes B cell responses.
Martinez-Martin N; Maldonado P; Gasparrini F; Frederico B; Aggarwal S; Gaya M; Tsui C; Burbage M; Keppler SJ; Montaner B; Jefferies HB; Nair U; Zhao YG; Domart MC; Collinson L; Bruckbauer A; Tooze SA; Batista FD
Science; 2017 Feb; 355(6325):641-647. PubMed ID: 28183981
[TBL] [Abstract][Full Text] [Related]
28. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
29. Deficiency in WDFY4 reduces the number of CD8
Li Y; Li J; Yuan Q; Bian X; Long F; Duan R; Gao F; Gao S; Wei S; Wang A; Liu A; Li X; Sun W; Liu Q
Mol Immunol; 2021 Nov; 139():131-138. PubMed ID: 34482201
[TBL] [Abstract][Full Text] [Related]
30. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A
Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989
[TBL] [Abstract][Full Text] [Related]
31. Maintenance of autoantibody production in pristane-induced murine lupus.
Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
[TBL] [Abstract][Full Text] [Related]
32. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
33. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells.
Sobel ES; Mohan C; Morel L; Schiffenbauer J; Wakeland EK
J Immunol; 1999 Feb; 162(4):2415-21. PubMed ID: 9973523
[TBL] [Abstract][Full Text] [Related]
34. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
Pan HF; Leng RX; Tao JH; Li XP; Ye DQ
Lupus; 2011 Mar; 20(3):227-30. PubMed ID: 21362749
[TBL] [Abstract][Full Text] [Related]
35. Dickkopf-3 acts as a modulator of B cell fate and function.
Ludwig J; Federico G; Prokosch S; Küblbeck G; Schmitt S; Klevenz A; Gröne HJ; Nitschke L; Arnold B
J Immunol; 2015 Mar; 194(6):2624-34. PubMed ID: 25672757
[TBL] [Abstract][Full Text] [Related]
36. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins.
Feuerstein N; Chen F; Madaio M; Maldonado M; Eisenberg RA
J Immunol; 1999 Nov; 163(10):5287-97. PubMed ID: 10553051
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
Levite M; Zinger H; Mozes E; Reisner Y
Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
[TBL] [Abstract][Full Text] [Related]
38. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
Hostmann A; Jacobi AM; Mei H; Hiepe F; Dörner T
Lupus; 2008 Dec; 17(12):1064-9. PubMed ID: 19029273
[TBL] [Abstract][Full Text] [Related]
39. Poly IC pretreatment suppresses B cell-mediated lupus-like autoimmunity through induction of Peli1.
Wang Y; Yuan J; Dai D; Liu J; Xu J; Miao X; Wang H; Mao C; Xiao Y
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):862-868. PubMed ID: 30032173
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
